Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Top Headlines

(Image: Getty/NicoElNino)

PE firm merging companies to create ‘one stop shop’ for medical affairs

The owners of Synteract, Amulet Capital Partners, have acquired a global health communications and market access group with plans to merge it with Peloton Advantage, which it purchased earlier this year.

Rho’s new business segment aims to streamline regulatory approval

Rho will expand its services with the addition of its Regulatory Strategy and Submissions business segment.

M&A in the CRO industry: The Good, The Bad, and The Ugly

M&A is a huge part of the CRO space. Inorganic growth has long been the go-to strategy for any CRO and we’re never surprised to see this month’s latest deal. However, I’d like to challenge the idea that this is always the best way to grow a CRO business.

Cambrex continues build-out at former PharmaCore site with $1m investment

Cambrex is investing $1m at its High Point, NC-based site, marking the most recent in a series of investments which will see the addition of 1,300 square feet and 15 new employees.

How the industry is addressing the ethical concerns of incorporating big data into health care

In the era of big data, the industry is working to address the ethical concerns of integrating patient information into the health care landscape – though a key challenge will be reaching a consensus on what constitutes reliable evidence.

From mouse to man: New machine-learning model reduces number of ‘wasted experiments’

The new “groundbreaking” model can translate the results of mouse experiments into the equivalent human condition, outperforming traditional methods of extrapolation by up to 50%, say researchers.

Global Industry News

Hot Topics

Spotlight

(Image: Getty/z_we)

Sponsors ‘still have further to go’ as 50% of trials go unreported: Report

(Image: Getty/peepo)

‘The opportunities for AI to revolutionize the pharmaceutical industry are clear’: Report

(Image: Getty/phive2015)

FDA looks to remove innovation barriers in digital health space, finding balance between speed and quality

(Image: Getty/metamorworks)

Less is more: Significant CDMO consolidation expected as pharma looks to work with fewer suppliers

(Image: Getty/RTimages)

Growing need for CRO expertise in early phase research, overall demand seeing stable growth: Report

(Image: Getty/siraanamwong)

FDA guidance on clinical trial data disclosure falls short, while noncompliance remains high

Follow us

Products

View more

Webinars

On-demand webinars

Featured Suppliers

All suppliers

Ajinomoto Bio-Pharma Services

Baxter BioPharma Solutions

Marken: Global Life Science Supply Chain Solutions

PRA Health Sciences

R-Pharm Germany GmbH